Status:
COMPLETED
Interactive Study to Increase Glaucoma Adherence to Treatment
Lead Sponsor:
Emory University
Conditions:
Glaucoma
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Study participants who receive the I-SIGHT intervention will have higher rates of glaucoma treatment compliance (e.g., medication-taking and refill compliance, return for clinical follow-up) and more ...
Detailed Description
The intervention is telephone-based and individually-tailored to participants' compliance knowledge, attitudes, and behaviors; psychosocial predictors of compliance; health literacy; race and culture;...
Eligibility Criteria
Inclusion
- Receive treatment at the Atlanta VA Medical Center or Grady Eye clinic for their eye condition
- Be between the ages of 18-80
- Be Caucasian or African American
- Possess a telephone (home telephone or cellular phone)
- Speak and understand English
- Be diagnosed with open angle glaucoma, be glaucoma suspect, or be ocular hypertensive for at least one year
- Be prescribed daily doses of topical treatments for at least one year
- Be able to read or have someone who can help the participant with reading written materials that we give to the participant
Exclusion
- Having eye surgery within 3 months of baseline interview and enrollment
- Being legally blind (20/200 or worse)
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2010
Estimated Enrollment :
312 Patients enrolled
Trial Details
Trial ID
NCT00794170
Start Date
August 1 2008
End Date
September 1 2010
Last Update
June 9 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Atlanta VA Medical Center
Atlanta, Georgia, United States, 30033
2
Grady Health System
Atlanta, Georgia, United States, 30303